
News|Articles|April 1, 2010
Formulary Digital Edition April 2010
Reducing cardiovascular risk is patients with type 2 diabetes: management of dyslipidemia; Focus on naproxicond; Drug Watch: Agents in late-stage development for the treatment of hepatitis C
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
3 things to know about CVS Health’s 2025 earnings
3
The invisible cost system: Why health plans keep missing millions in print and mail savings
4
Oral Wegovy, uACR test spotlighted in the health-oriented Super Bowl ads
5

























